News
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
3d
AZoLifeSciences on MSNHow Insects Are Helping Us Make New MedicinesThe role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable solutions for medical applications.
Zostavax and Shingrix are linked to protection for older adults in multiple studies.
4d
MyChesCo on MSNExpanded Recommendation for GSK’s AREXVY Vaccine Targets Adults at Higher Risk for Severe RSVPHILADELPHIA, PA — The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s ...
GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first vaccine in Egypt approved by the Egyptian Drug Authority for the ...
"We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook on Tuesday during his Make America Healthy Again tour in Arizona, marking the ...
Recall the Comirnaty® and Spikevax® mRNA-based vaccines each utilize lipid nanoparticles ... the Netherlands, and Belgium from 2022 to 2023. CureVac v. Pfizer+BioNTech In June 2022, longstanding ...
Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, said in an interview Tuesday that he encourages people to get vaccinated against measles after an outbreak has killed ...
April 8 (UPI) --Some 8,700 service members who were fired by the Biden administration for refusing to get COVID-19 vaccines are invited back to their former positions. "We're committed to doing ...
Kate Nalepinski is a Newsweek journalist based in New York City. Kate joined Newsweek in May 2024. She is a graduate of Ithaca College. Secretary of Health and Human Services Robert F. Kennedy Jr ...
GSK filed suit in August 2023, alleging that Pfizer’s respiratory syncytial virus (“RSV”) vaccine, ABRYSVO, infringes four U.S. patents covering GSK’s rival RSV vaccine, AVREXY.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results